The United Laboratories International Holdings Limited
ULIHF
$1.64
-$0.1543-8.60%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 81.21M | 81.60M | 102.98M | 103.87M | 98.12M |
| Total Depreciation and Amortization | 20.34M | 20.44M | 21.06M | 21.25M | 17.11M |
| Total Amortization of Deferred Charges | 1.24M | 1.24M | -- | -- | 1.09M |
| Total Other Non-Cash Items | -18.12M | -18.21M | 4.84M | 4.88M | 1.98M |
| Change in Net Operating Assets | 9.43M | 9.48M | -1.45M | -1.46M | -32.28M |
| Cash from Operations | 94.09M | 94.55M | 127.43M | 128.53M | 86.01M |
| Capital Expenditure | -65.06M | -65.38M | -53.80M | -54.26M | -55.71M |
| Sale of Property, Plant, and Equipment | 544.20K | 546.90K | 116.30K | 117.30K | 146.70K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -19.20M | -19.29M | 17.52M | 17.68M | -25.83M |
| Cash from Investing | -83.72M | -84.12M | -36.16M | -36.47M | -81.40M |
| Total Debt Issued | 578.99M | 578.99M | 534.80M | 534.80M | 400.00M |
| Total Debt Repaid | -230.91M | -230.91M | -64.80M | -64.80M | -375.28M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -18.23M | -18.23M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -55.57M | -55.84M | -- | -- | -32.72M |
| Other Financing Activities | -116.83M | -116.83M | 15.18M | 15.18M | -62.47M |
| Cash from Financing | -25.96M | -26.08M | 67.00M | 67.58M | -37.94M |
| Foreign Exchange rate Adjustments | -57.80K | -58.10K | 39.00K | 39.30K | -103.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.64M | -15.71M | 158.31M | 159.68M | -33.44M |